World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
47760
World Ranking
11085
National Ranking
5703

Rohit Mehra publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Rohit Mehra sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 384 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Rohit Mehra D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Rohit Mehra sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Rohit Mehra is affiliated with the University of Michigan-Ann Arbor in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong emphasis on oncology-related subfields such as Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Cancer Research, and Oncology.

Their main topics of work include renal cell carcinoma treatment, prostate cancer treatment and research, prostate cancer diagnosis and treatment, renal and related cancers, cancer genomics and diagnostics, bladder and urothelial cancer treatments, as well as ferroptosis and cancer prognosis.

Mehra has extensively published research articles in several notable venues. Frequent publication venues include:

  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Cancer Research
  • The Journal of Urology
  • Modern Pathology

Some recent papers reflect the range and focus of their work:

  • Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response (2021, Proceedings of the National Academy of Sciences)
  • Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer (2021, Nature)
  • The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer (2020, Archives of Pathology & Laboratory Medicine)
  • New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021, Modern Pathology)
  • Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia (2021, Modern Pathology)

Collaboration is a significant aspect of Mehra's work, with frequent co-authors including Arul M. Chinnaiyan, Todd M. Morgan, Rahul Mannan, Daniel E. Spratt, and Xuhong Cao. These partnerships have contributed to a substantial body of published research, underscoring multidisciplinary efforts in cancer research and treatment.

Best Publications

  • Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

    S.A. Tomlins;D.R. Rhodes;S. Perner;S.M. Dhanasekaran

  • Integrative clinical genomics of advanced prostate cancer

    Dan Robinson;Eliezer M. Van Allen;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • The mutational landscape of lethal castration-resistant prostate cancer

    Catherine S. Grasso;Yi Mi Wu;Dan R. Robinson;Xuhong Cao

  • Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

    Arun Sreekumar;Laila M. Poisson;Thekkelnaycke M. Rajendiran;Amjad P. Khan

  • Integrative molecular concept modeling of prostate cancer progression

    Scott A Tomlins;Rohit Mehra;Daniel R Rhodes;Xuhong Cao

  • Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer

    Qianben Wang;Wei Li;Yong Zhang;Xin Yuan

  • Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

    Scott A. Tomlins;Bharathi Laxman;Saravana M. Dhanasekaran;Beth E. Helgeson

  • Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.

    Sooryanarayana Varambally;Jianjun Yu;Bharathi Laxman;Daniel R. Rhodes

  • Role of the TMPRSS2-ERG gene fusion in prostate cancer

    Scott A. Tomlins;Bharathi Laxman;Sooryanarayana Varambally;Xuhong Cao

  • Recurrent gene fusions in prostate cancer

    Scott Tomlins;Daniel Rhodes;Arul Chinnaiyan;Rohit Mehra

  • Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

    Michael A. Gillette;Michael A. Gillette;Shankha Satpathy;Song Cao;Saravana M. Dhanasekaran

  • Autoantibody Signatures in Prostate Cancer

    X. Wang;J. Yu;A. Sreekumar;S. Varambally

  • Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program.

    Rajal B. Shah;Rohit Mehra;Arul M. Chinnaiyan;Ronglai Shen

  • Repression of E-cadherin by the polycomb group protein EZH2 in cancer

    Qi Cao;J. Yu;S. M. Dhanasekaran;J. H. Kim

  • The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer

    Jianhua Wang;Yusuke Shiozawa;Jincheng Wang;Yu Wang

  • TMPRSS2:ETV4 Gene Fusions Define a Third Molecular Subtype of Prostate Cancer

    Scott A. Tomlins;Rohit Mehra;Daniel R. Rhodes;Lisa R. Smith

  • A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer

    Bharathi Laxman;David S. Morris;Jianjun Yu;Javed Siddiqui

  • Erratum: Integrative Clinical Genomics of Advanced Prostate Cancer

    Dan Robinson;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.

    J. Chad Brenner;Bushra Ateeq;Yong Li;Anastasia K. Yocum

  • Antibody-based detection of ERG rearrangement-positive prostate cancer.

    Kyung Park;Scott A. Tomlins;Kumaran M. Mudaliar;Ya Lin Chiu

Frequent Co-Authors

Arul M. Chinnaiyan
Arul M. Chinnaiyan University of Michigan–Ann Arbor
Scott A. Tomlins
Scott A. Tomlins University of Michigan–Ann Arbor
Xuhong Cao
Xuhong Cao University of Michigan–Ann Arbor
Javed Siddiqui
Javed Siddiqui University of Michigan–Ann Arbor
Daniel E. Spratt
Daniel E. Spratt University of Michigan–Ann Arbor
Saravana M. Dhanasekaran
Saravana M. Dhanasekaran University of Michigan–Ann Arbor
Mark A. Rubin
Mark A. Rubin University of Bern
Sooryanarayana Varambally
Sooryanarayana Varambally University of Alabama at Birmingham
Kenneth J. Pienta
Kenneth J. Pienta Johns Hopkins University School of Medicine
John T. Wei
John T. Wei University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in Medicine but exploring flexible or alternative career paths, there are many online healthcare degrees worth considering. For those seeking an entry-level option, lpn online programs offer a chance to become a Licensed Practical Nurse quickly and conveniently from home.

If you aim to advance further, specialist nurse practitioners are in high demand—especially in mental health. The shortest pmhnp program options online let experienced nurses qualify as Psychiatric Mental Health Nurse Practitioners with an efficient path to a rewarding field.

Beyond clinical roles, healthcare administration is a growing area with stable job prospects. The best online mha programs and affordable mha online degrees can help you build leadership and business skills, qualifying you for management positions in hospitals, clinics, and other medical organizations.

These accredited online degrees offer flexibility and a practical path to begin or advance your career in healthcare.

Best Scientists Citing Rohit Mehra

Trending Scientists

Recently Published Articles